Mouchlis, V.D.; Afantitis, A.; Serra, A.; Fratello, M.; Papadiamantis, A.G.; Aidinis, V.; Lynch, I.; Greco, D.; Melagraki, G.
Advances in De Novo Drug Design: From Conventional to Machine Learning Methods. Int. J. Mol. Sci. 2021, 22, 1676.
https://doi.org/10.3390/ijms22041676
AMA Style
Mouchlis VD, Afantitis A, Serra A, Fratello M, Papadiamantis AG, Aidinis V, Lynch I, Greco D, Melagraki G.
Advances in De Novo Drug Design: From Conventional to Machine Learning Methods. International Journal of Molecular Sciences. 2021; 22(4):1676.
https://doi.org/10.3390/ijms22041676
Chicago/Turabian Style
Mouchlis, Varnavas D., Antreas Afantitis, Angela Serra, Michele Fratello, Anastasios G. Papadiamantis, Vassilis Aidinis, Iseult Lynch, Dario Greco, and Georgia Melagraki.
2021. "Advances in De Novo Drug Design: From Conventional to Machine Learning Methods" International Journal of Molecular Sciences 22, no. 4: 1676.
https://doi.org/10.3390/ijms22041676
APA Style
Mouchlis, V. D., Afantitis, A., Serra, A., Fratello, M., Papadiamantis, A. G., Aidinis, V., Lynch, I., Greco, D., & Melagraki, G.
(2021). Advances in De Novo Drug Design: From Conventional to Machine Learning Methods. International Journal of Molecular Sciences, 22(4), 1676.
https://doi.org/10.3390/ijms22041676